Changes in Disease-Modifying Antirheumatic Drug Treatment for Patients With Rheumatoid Arthritis in the US During the COVID-19 Pandemic: A Three-Month Observational Study.

Kaleb D MichaudSofia PedroKristin WipflerEkta AgarwalPatricia P Katz

Published in: Arthritis care & research (2021)

Persons with RA in the US made substantial medication changes during the first three months of the COVID-19 pandemic, and changes among persons with RA after publication of the ACR guidance in April 2020 were made with increased physician guidance.

Keyphrases

rheumatoid arthritis
disease activity
emergency department
healthcare
ankylosing spondylitis
adverse drug
interstitial lung disease
systemic lupus erythematosus
systemic sclerosis